Shopping Cart
- Remove All
- Your shopping cart is currently empty
SHP2-IN-9 is a potent inhibitor (IC50 = 1.174 μM) specifically targeting the SHP2 protein, displaying improved penetration across the blood-brain barrier. It exhibits a remarkable 85-fold selectivity for SHP2 over SHP1. By inhibiting SHP2-mediated cell signal transduction and impairing cancer cell proliferation, SHP2-IN-9 effectively suppresses the growth of both cervix cancer tumors and glioblastoma in vivo [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $86 | 5 days |
Description | SHP2-IN-9 is a potent inhibitor (IC50 = 1.174 μM) specifically targeting the SHP2 protein, displaying improved penetration across the blood-brain barrier. It exhibits a remarkable 85-fold selectivity for SHP2 over SHP1. By inhibiting SHP2-mediated cell signal transduction and impairing cancer cell proliferation, SHP2-IN-9 effectively suppresses the growth of both cervix cancer tumors and glioblastoma in vivo [1]. |
In vitro | SHP2-IN-9 (compound 2) effectively disrupts SHP2-mediated cell signaling in various cancers (cervix cancer, human pancreatic cancer, large cell lung cancer, and mouse glioma cell) by inhibiting Paxillin phosphorylation, interfering with PI3K/AKT pathway regulation, and inhibiting cell proliferation, resulting in cell cycle arrest and early apoptosis induction [1]. |
Molecular Weight | 385.46 |
Formula | C20H20FN3O2S |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.